Literature DB >> 2841248

Transformation of primary human fibroblast cells with human papillomavirus type 16 DNA and EJ-ras.

G Matlashewski1, K Osborn, L Banks, M Stanley, L Crawford.   

Abstract

Human papillomavirus type 16 (HPV type 16) has been implicated as an etiological agent in human cervical cancer. This virus contains sequences which, under the proper transcriptional control, can increase the tumorigenicity of established mouse cells and cooperate with EJ-ras in transforming primary baby rat kidney (BRK) cells. These data argue that this virus contains oncogenic sequences. Because this is a human virus, it was important to study the effect on primary human cells of HPV type-16 DNA in both the presence and absence of EJ-ras. We now present data which demonstrate that HPV type-16 DNA, under the transcriptional control of Moloney murine leukemia viral long terminal repeats (MoMuLV-LTR), can extend the life span of primary human fibroblast cells in culture. Co-transfection of the HPV type-16 DNA containing plasmid together with an activated EJ-ras oncogene gives rise to transformed cells which grow faster, are morphologically different from and more aneuploid than cells established with only HPV type-16 DNA. Molecular analysis of these established and partially transformed human cells reveals that they contain and express the transfected DNA. These data argue that primary human cells can be transformed with HPV type-16 and EJ-ras sequences, whereas cells harboring only HPV type 16 DNA are largely normal but have an extended life span.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841248     DOI: 10.1002/ijc.2910420215

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Epithelial cells immortalized by human papillomaviruses have premalignant characteristics in organotypic culture.

Authors:  R A Blanton; N Perez-Reyes; D T Merrick; J K McDougall
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

Review 2.  Human papillomavirus, integration and cervical carcinogenesis: a clinicopathological perspective.

Authors:  K Cooper; J O McGee
Journal:  Mol Pathol       Date:  1997-02

Review 3.  Human papillomaviruses and cervical neoplasia. II. Interaction of HPV with other factors.

Authors:  C S Herrington
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

4.  A research for the relationship between human papillomavirus and human uterine cervical carcinoma. II. Molecular genetic and ultrastructural study on the transforming activity of recombinant retrovirus containing human papillomavirus type 16 subgenomic sequences.

Authors:  J Y Si; K Lee; W Zhang; R C Han; G X Song; L F Chen; W M Zhao; L P Jia; S Liu; Y Y Mai
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

5.  Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis.

Authors:  S Jeon; P F Lambert
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

6.  Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells.

Authors:  S Jeon; B L Allen-Hoffmann; P F Lambert
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

7.  Persistence of high-grade cervical dysplasia and cervical cancer requires the continuous expression of the human papillomavirus type 16 E7 oncogene.

Authors:  Sean F Jabbar; Linda Abrams; Adam Glick; Paul F Lambert
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

Review 8.  Molecular events in uterine cervical cancer.

Authors:  S A Southern; C S Herrington
Journal:  Sex Transm Infect       Date:  1998-04       Impact factor: 3.519

9.  Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV-16 plus EJ-ras.

Authors:  T Crook; J P Morgenstern; L Crawford; L Banks
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

10.  Loss of heterozygosity occurs at the D11S29 locus on chromosome 11q23 in invasive cervical carcinoma.

Authors:  P B Bethwaite; J Koreth; C S Herrington; J O McGee
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.